Max Weaver

MedicinePharmacology, Toxicology and PharmaceuticsBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world setting”.

Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world setting

European Journal of Human Genetics(2024)10.1038/s41431-024-01567-1

N/A

0.345DataRank · unranked

9 citations

Kurt D. Christensen, Joel Van Heukelom, April Schultz, Muhammad Hamza Saad Shaukat, Catherine Hajek +8 more

Evaluation of the impact of CYP2D6 testing on outcomes in patients taking opioids

Journal of the American Pharmacists Association(2025)10.1016/j.japh.2025.102905

N/A

0.104DataRank · unranked

1 citations

Max Weaver, Jordan Baye, Amanda Massmann, Halle Brady